NASDAQ OMX

Addivant(TM) Launches NAUGARD® FOAMPLUS, New Ultra-Low Emissive Antioxidant Solutions for Flexible Polyurethane Foams in Automotive Applications

Dela

DANBURY, Conn., May 15, 2017 (GLOBE NEWSWIRE) -- Addivant(TM), a global leader in polymer additive technologies, today announced the launch of the NAUGARD® FOAMPLUS LE solutions, a next generation liquid antioxidant for the polyurethane industry. Developed to meet the challenges faced in automotive applications, the NAUGARD® FOAMPLUS LE portfolio comprises ultra-low emissive stabilization packages enabling the entire value chain to be compliant with the ever-stricter national legislations on vehicle indoor air quality (VIAQ). Addivant will make the announcement during the Chinaplas 2017 exhibition (Booth 9.3M01) May 16-19 in Guangzhou, PR of China.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/d8aef4a9-0533-44c3-9ebd-4a1280812210

The NAUGARD® FOAMPLUS LE series has been designed to be inherently more thermally stable to provide excellent scorch protection and polyol stability. Another important advantage is that the liquid antioxidants provide improved handling with a better viscosity profile than existing competitive materials. The new solutions are less volatile than the industry benchmarks at high foaming temperatures, resulting in more than a 90% reduction in VOC (Volatile Organic Compound) & FOG emissions.

"We are excited to launch our NAUGARD® FOAMPLUS LE series this week during Chinaplas." said John Steitz, President and CEO of Addivant.  "China is the largest automobile market in the world and it is quickly implementing some of the most stringent environmental and quality standards in the world." The new breakthrough series builds on Addivant's reputation for technology and quality, complementing a comprehensive portfolio of solutions for polyol producers and downstream foamers.

The NAUGARD® FOAMPLUS LE series has been extensively researched and tested to be fully compliant with the VOC and FOG limits set by Germany's VDA 278 emission standard which is part of the delivery specifications of leading automobile companies such as Daimler, BMW, Porsche, and VW. Furthermore, the new solutions maintain or improve upon the other critical performance parameters required by polyol and polyurethane system houses and foam producers.

The new FOAMPLUS LE series is an easy drop-in replacement for existing stabilization packages, allowing customers to switch quickly without any investments or plant modifications. Addivant provides peace of mind to the global polyurethane industry by supporting customer's global standards with worldwide manufacturing and technical support capabilities.

The automotive industry is increasingly replacing traditional materials with polyurethanes to deliver greater comfort, meet higher fuel efficiency standards and provide greater safety and design flexibility. Addivant is well positioned to help the polyurethane industry meet these challenges with the broadest range of specialty solutions in the market.

Addivant is an independent portfolio company of SK Capital.

Addivant(TM) and NAUGARD® are trademarks of Addivant.

Company Contacts:
Americas: Beverly Kindermann: +1 203 702 6182
Europe: Irfaan Foster: +32 479 991 965
Asia Pacific: Bill Xu: +86 216 032 6822




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Addivant via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Standard Lithium Announces Closing of $21.6 million Bought Deal Private Placement of Units16.2.2018 19:25Pressmeddelande

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSX-V:SLL) (OTCQX:STLHF) (FRA:S5L) announced today that it has closed its previously announced bought deal private placement of 10,312,821 units of the Company (the "Units"), at a price of $2.10 per Unit, for aggregate gross proceeds to the Company of $21,656,924, including the issuance and sale of the Underwriters' (as defined below) option (the "Offering"). Each Unit consists of one common share of the Company and one-half of one common share purchase warrant (each whole common share purchase warrant, a "Warrant"). Each Warrant is exercisable to acquire one common share of the Company (a "Warrant Share") until February 16, 2020 at an exercise price of $2.60 per Warrant Share, subject to adjus

Cisco Offers Cloud-Based Endpoint Security Solutions for Managed Security Service Providers16.2.2018 14:00Pressmeddelande

Cisco's comprehensive cloud-based security endpoint portfolio provides advanced malware protection, internet security, and enterprise mobility management SAN JOSE, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Cisco today is helping address the challenges of Managed Security Service Providers (MSSP) and their customers by offering MSSPs comprehensive security, visibility, and control of customer endpoints without added hardware or complexity. The Cisco endpoint security portfolio includes three industry-leading solutions-Cisco AMP for Endpoints, Cisco Umbrella, and Meraki Systems Manager to offer protection against advanced malware and threats. Security teams know the endpoints in their environments are being targeted by advanced threats, but often lack the security talent, tools, and budget to address those challenges. As a result, organizations of all sizes are choosing to augment their in-house IT security with managed security services. Nearly half of SMBs and enterprises in the US1 ar

Aurora Solar Adds Heterojunction Cell Characterization to Decima Gemini Family16.2.2018 14:00Pressmeddelande

Aurora Solar Technologies Inc. / Aurora Solar Adds Heterojunction Cell Characterization to Decima Gemini Family . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. NORTH VANCOUVER, British Columbia, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Aurora Solar Technologies Inc. ("Aurora") ("Company") (TSX.V:ACU) (OTCBB:AACTF) (FSE:A82) is pleased to provide an update on the further development of its Decima Gemini(TM) infrared measurement technology for applications in the rapidly developing heterojunction (HJT) cell manufacturing market. HJT is an ultra high-efficiency solar cell design pioneered by Japan's Panasonic Corp., who is now also partnered with Tesla Inc. for solar products. According to Solar Media Ltd., HJT production capacity is expected to increase by 20 percent this year. To produce the electrical structure of a HJT cell, it is necessary to apply thin layers of amorphous silicon on both sides of a crystallin

Nasdaq Cited as a Leader in Governance, Risk, and Compliance Platforms by Independent Research Firm16.2.2018 13:35Pressmeddelande

NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) was among the select companies that Forrester invited to participate in its 2018 Forrester Wave(TM) evaluation, Governance, Risk, And Compliance (GRC) Platforms, Q1 2018. In this evaluation, Nasdaq was cited as a Leader in Governance, Risk, and Compliance Platforms and received the maximum score of 5 for the evaluation criteria "Risk & Control Management", "Audit Management", "Dashboard and Reporting" and "Integration capabilities" for its BWise solutions. "We feel the strong scores we obtained in important functional areas provide assurance to our clients that they have selected a robust and future-proof software platform," said Tom Passon, Head of Product Innovation & Global Standards, Nasdaq BWise. "We are proud of this recognition that encourages us to further execute on our strategy to provide user-friendly, pre-configured best practice solutions that combine our innovative GRC software platform with leading expertis

Mandalay Resources Provides Target Release Date for Fourth Quarter and Full-Year 2017 Financial Results and Conference Call16.2.2018 13:30Pressmeddelande

TORONTO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation ("Mandalay" or "the Company") (TSX:MND) today announced that its fourth quarter and full-year 2017 financial results will be released after market close on February 21, 2018, followed by a conference call with Mark Sander, President and Chief Executive Officer of Mandalay, for investors and analysts on February 22, 2018 at 8:00 am (Toronto time). Analysts and interested investors are invited to participate using the following dial-in numbers: Participant Number: (201) 689-8341 Participant Number (Toll free): (877) 407-8289 Conference ID: 13676606 A replay of the conference call will be available until 11:59 pm (Toronto time), March 8, 2018 and can be accessed using the following dial-in number: Encore Toll Free Dial-in Number: (877) 660-6853 Encore ID: 13676606 For Further Information: Mark Sander President and Chief Executive Officer Greg DiTomaso Director of Investor Relations Contact: +1.647.260.1566 About Man

Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros(TM)16.2.2018 13:00Pressmeddelande

Company Evaluating Deficiencies and Potential Path Forward SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the U.S. Food and Drug Administration ("FDA") has issued a complete response letter ("CRL") for the New Drug Application ("NDA") of Vitaros(TM) (alprostadil, DDAIP.HCl), a topical cream for the treatment of erectile dysfunction. The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form, identifying deficiencies related to Chemistry, Manufacturing and Control ("CMC") and certain safety concerns specific to the 2.5% concentration of DDAIP.HCl contained in the current formulation. "We are disappointed with the outcome of the review given the substantial amount of CMC, clinical and non-clinical data and analysis provided to the FDA in the Vitaros resubmission. We are assessing the content of the complete response

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum